From the Society's perspective

摘要

As the recently appointed chairman of the Royal Pharmaceutical Society's Education Committee,I would like to take the opportunity to respond to the concerns of Ian Dean(PJ,13 August,pi94)and other colleagues.When the Royal Pharmaceutical Society's Council took its decision in 2003 to end reciprocal agreements with Australia and New Zealand it did so knowing the decision would be controversial.As Mr Dean points out,the Society thought a continuance of the existing agreements could be "construed as being discriminatory and risk legal challenge".A key part of our thinking was the knowledge that new legislation stemming from the 1999 Health Act would not allow for reciprocal arrangements(not just for pharmacists but other professions too).